ATLANTA, GA/ACCESSWIRE/July 18, 2022/ Findit, Inc., a Nevada corporation (OTC PINK: FDIT) Owner of Findit.coma social media management platform and online marketing service, was retained by BioRegenx to provide them with a comprehensive online marketing campaign to improve and increase their organic search results and build their brand on social networks.
BioRegenx will receive content creation and posting via Findit as well as social sharing. Findit will regularly produce SEO-focused content, driving traffic to BioRegenx and its affiliates to improve overall search engine indexing.
As part of their campaign, Findit will create, publish and share freshly written content via Findit URLs that BioRegenx will receive as part of its ongoing marketing campaign. Findit will identify BioRegenx URLs that will be specific to the keywords BioRegenx wants to highlight and drive traffic. Content created through these URLs will consist of Right Now status updates. Once posts are live, they may be shared on other social media sites which include, but are not limited to: Facebook, LinkedIn, Pinterest, Tumblr, and Twitter. As part of their marketing campaigns, videos may also be produced to aid in online indexing.
Findit is setting up URLs for BioRegenx which are part of their campaign. URL setup includes creating photo galleries with photos that include titles and descriptions that help with search engine indexing as well as setting up contact information and a link back to their website .
BioRegenx, Inc., (https://bioregenx.com/) a holding company, consists of Microvascular Health Solutions, LLC, My Body Rx, LLC and NuLife Sciences, Inc. BioRegenx and its subsidiaries combine the patented intellectual property of the revolutionary medical test device GlycoCheck, the patented nutraceutical Endocalyx Pro, additional synergistic dietary supplement products sold under the My Body Rx brand, and a customer base of healthcare professionals and brand partners across North America.
Microvascular Health Solutions (MVHS) is a research and product development, sales, education and marketing company that developed the patented and clinically tested dietary supplement Endocalyx Pro™ to improve endothelial glycocalyx health. Additionally, MVHS exclusively manufactures, sells and distributes patented GlycoCheck™ software and a Class 1 medical device that measures and analyzes the endothelial glycocalyx, a transparent lining inside all blood vessels.
My Body Rx™ is a manufacturing, sales and product development company that produces dietary supplements that complement and work synergistically with the patented and clinically tested Endocalyx Pro™ product to support and enhance healthy aging and increase longevity.
NuLife Sciences, Inc. is a marketing and distribution company whose mission is to harness advanced technologies to redefine health and longevity. This is achieved by improving understanding of the biology that controls lifespan and anti-aging in the human body. NuLife exclusively markets the My Body Rx™ line of supplements. NuLife will also distribute GlycoCheck™, TruEpigenetics and other new products currently in development.
Findit.com, which is a social media content management platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that allows Google, Yahoo, Bing and other search engines to access its content posted on Findit so that it can also be indexed in these search engines. Findit offers members the ability to publish, share and manage their content. Once they’ve been published to Findit, we make sure the content is indexed in Findit search results. Findit offers anyone the ability to submit URLs they want indexed in Findit search results, as well as post status updates through Findit Right Now. Status updates posted to Findit may be crawled by external search engines, which may result in additional organic indexing. All posts on Findit can be shared on other social and bookmarking sites by members and non-members. Findit offers real estate agents the ability to create their own Findit site where they can pull their listing and others through their IDX account. Findit, Inc. is focused on developing monetized web products on the Internet that can increase brand awareness among our members. Findit, Inc. trades under the ticker symbol FDIT on the OTC Pinksheets.
This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements regarding potential sales, the success of the company’s business , as well as statements that include the word believe or similar expressions. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Findit, Inc.’s actual results, performance or achievements to differ materially from those implied or expressed.
THE SOURCE: Findit, Inc.
See the source version on accesswire.com: